Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Voen Med Zh ; 331(12): 4-8, 2010 Dec.
Article in Russian | MEDLINE | ID: mdl-21488354

ABSTRACT

By the example of rheumatoid arthritis was considered the methods of economic assessment of advisability of modern biological medication usage in military medicine. The usage of these medications leads to quick clinical response, decrease of the additional medication intake, decrease of the average duration of treatment, "move aside" time of permanent disablement. Modern active therapy can increase the effectiveness of treatment; improve the quality of life, decrease the average duration of hospital stay, following treatment expense and welfare payment for this category of ill.


Subject(s)
Antibodies, Monoclonal/economics , Drug Costs , Military Medicine/economics , Adalimumab , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antibodies, Monoclonal, Murine-Derived/administration & dosage , Antibodies, Monoclonal, Murine-Derived/economics , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/economics , Cost-Benefit Analysis , Humans , Infliximab , Military Personnel , Rituximab , Russia
SELECTION OF CITATIONS
SEARCH DETAIL
...